semaglutide and visceral fat GLP-1 drugs are often framed as weight-loss drugs, but that perspective overlooks their deeper biology. Randomized trials show meaningful effects on cardiovascular events, fat, kidney health, inflammation. already has Government declares 'national shortage' Gastrointestinal Health Flavor:Raspberry Lemon

semaglutide and visceral fat GLP-1 drugs are often framed as weight-loss drugs, but that perspective overlooks their deeper biology. Randomized trials show meaningful effects on cardiovascular events, fat, kidney health, inflammation. already has Government declares 'national shortage' Gastrointestinal Health Flavor:Raspberry Lemon

Government declares 'national shortage' of GLP-1 receptor agonists for type 2 diabetes until 2024 - The Pharmaceutical Journal

Cagrilintide had one of the lowest GI odds ratios among incretin-class compounds in a 2025 network meta-analysis, but combination GI burden has not been formally quantified

Gastrointestinal Health

Flavor:Raspberry Lemon

Although exendin-3 and exendin-(9–39) have also been involved as other ligands in studies of insulinoma and pancreatic β-cell mass determination